Tianci International Pharmaceutical
Latest round
- Series C
Last raised
- Dec 2015
Total raised
- Undisclosed
Investors
- 2
About Tianci International Pharmaceutical
Establishd in 2013 and based in Shanghai, China, Tianci International Pharmaceutical operates as a pharmaceutical industry chain aggregation platform that focuses on drug research and development technical support. The company focuses on the research and development of new drugs and APIs. The products mainly include innovative drugs and generic drugs. Innovative drugs include therapeutic biological products, Class 1 innovative thrombolytic drugs HTUPA, IDO inhibitors, and mannooligosaccharide diacid capsules. The generic drug is amlodipine besylate tablets, which are used to treat cardiovascular diseases such as hypertension and coronary heart disease. The company generates revenue by providing new drugs and APIs.
Who invested in Tianci International Pharmaceutical
2 investors across 1 round
See all investors in Tianci International Pharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Dec 24, 2015
Amount
Undisclosed
Investors
Questions about Tianci International Pharmaceutical
Who invested in Tianci International Pharmaceutical?
Tianci International Pharmaceutical has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tianci International Pharmaceutical raised?
Tianci International Pharmaceutical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tianci International Pharmaceutical last raise money?
Tianci International Pharmaceutical's most recent round on record is a Series C, in Dec 2015.
What does Tianci International Pharmaceutical do?
Establishd in 2013 and based in Shanghai, China, Tianci International Pharmaceutical operates as a pharmaceutical industry chain aggregation platform that focuses on drug research and development technical support.
Where is Tianci International Pharmaceutical headquartered?
Tianci International Pharmaceutical is headquartered in Shanghai, China.
Which VCs invest in companies like Tianci International Pharmaceutical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Tianci International Pharmaceutical's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Tianci International Pharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.